Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.59 |
| ▸ | SLC5A1 | P13866 | 3/20 | 0.57 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.57 |
| ▸ | SLC28A3 | Q9HAS3 | 5/20 | 0.55 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | G6PD | P11413 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4635767 | 0.90 | TYR (0.59) | TYRSLC5A1SLC5A2SLC28A3AKR1B1 | |
| SCHEMBL31131425 | 0.89 | SLC28A3 (0.63) | TYRSLC5A1SLC5A2SLC28A3AKR1B1 | |
| SCHEMBL4635652 | 0.86 | SNCA (0.58) | TYRSLC5A1SLC5A2SLC28A3AKR1B1 | |
| SCHEMBL5437894 | 0.86 | ACHE (0.50) | TYRSLC5A1SLC5A2SLC28A3ACHE | |
| SCHEMBL5427382 | 0.86 | ACHE (0.50) | TYRSLC5A1SLC5A2SLC28A3ACHE | |
| SCHEMBL5427804 | 0.86 | ACHE (0.50) | TYRSLC5A1SLC5A2SLC28A3ACHE | |
| SCHEMBL17873961 | 0.86 | ACHE (0.50) | TYRSLC5A1SLC5A2SLC28A3ACHE | |
| SCHEMBL4636842 | 0.84 | TYR (0.53) | TYRSLC5A1SLC5A2SLC28A3AKR1B1 | |
| SCHEMBL7781046 | 0.84 | SLC5A1 (0.58) | TYRSLC5A1SLC5A2SLC28A3AKR1B1 | |
| SCHEMBL7780290 | 0.83 | TYR (0.52) | TYRSLC5A1SLC5A2SLC28A3AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260047977-A1 | DEVICE AND METHOD OF USE FOR MEASURING AND MODIFYING THE ORBITAL AND INTRAORBITAL CONTENT, VOLUME, PULSALITY, LYMPHATIC DRAINAGE, VENOUS DRAINAGE, AND BLOOD FLOW | SHAZLY TAREK A (US) | 2026-02-19 | — | — | US | disclosed |
| EP-4583978-A2 | MEDICAL USE OF CCR8 ANTIBODIES AND DOSING SCHEDULE | Bayer Aktiengesellschaft (DE) | 2025-07-16 | — | — | EP | disclosed |
| CN-118871121-A | Antimicrobial natural compositions | 生物活性协同有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-118660702-A | Antimicrobial compositions | 生物活性协同有限公司 | 2024-09-17 | — | — | CN | disclosed |
| WO-2024059080-A2 | DEVICE AND METHOD OF USE FOR MEASURING AND MODIFYING THE ORBITAL AND INTRAORBITAL CONTENT, VOLUME, PULSALITY, LYMPHATIC DRAINAGE, VENOUS DRAINAGE, AND BLOOD FLOW | SHAZLY TAREK A (US) | 2024-03-21 | — | — | WO | disclosed |
| WO-2024052517-A2 | MEDICAL USE OF CCR8 ANTIBODIES AND DOSING SCHEDULE | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| US-11917995-B2 | Fungicidal compositions of mefentrifluconazole | BASF Agro B.V. (NL) | 2024-03-05 | — | — | US | disclosed |
| CN-114920792-B | Steroid compound and preparation method and application thereof | 中国农业科学院烟草研究所(中国烟草总公司青州烟草研究所) | 2023-04-14 | — | — | CN | disclosed |
| CN-113598173-B | Fungicidal composition and method for controlling harmful fungi | 石原产业株式会社 | 2022-11-04 | — | — | CN | disclosed |
| CN-109561852-B | Medical image processing system and method for personalized customized diagnosis and status determination of brain diseases | 李昡燮 | 2022-09-06 | — | — | CN | disclosed |
| CN-114907434-A | Sorbicillinoid derivative and preparation method and application thereof | 中国农业科学院烟草研究所(中国烟草总公司青州烟草研究所) | 2022-08-16 | — | — | CN | disclosed |
| CN-111801014-B | Fungicidal compositions of cloroxen | 巴斯夫农业公司 | 2022-05-27 | — | — | CN | disclosed |
| EP-1932514-B1 | PHARMACEUTICAL PREPARATION FOR EXTERNAL APPLICATION TO SKIN COMPRISING PHOSPHORYLATED SUGAR | EZAKI GLICO CO (JP) | 2018-11-14 | — | — | EP | disclosed |
| US-20140023602-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING A PHOSPHORYLATED SACCHARIDE | EZAKI GLICO CO., LTD. (JP) | 2014-01-23 | — | — | US | disclosed |
| US-20080274068-A1 | External Preparation for Skin Containing a Phosphorlated Saccharide | EZAKI GLICO CO., LTD. (JP) | 2008-11-06 | — | — | US | disclosed |
| EP-1932514-A1 | PHARMACEUTICAL PREPARATION FOR EXTERNAL APPLICATION TO SKIN COMPRISING PHOSPHORYLATED SUGAR | Ezaki Glico Co., Ltd. (JP) | 2008-06-18 | — | — | EP | disclosed |
| EP-0649648-B1 | Skin whitening agents containing glycosides | SHISEIDO CO LTD (JP) | 2001-09-19 | — | — | EP | disclosed |
| US-5700784-A | GLYCOSIDES OF HYDROXYSALICYLIC ACID AND/OR GLYCOSIDES OF ESTERS OF HYDROXYSALICYLIC ACID; EXCELLENT WHITENING EFFECT AND SKIN CARE EFFECT | SHISEIDO CO., LTD. (JP) | 1997-12-23 | — | — | US | disclosed |
| EP-0649648-A2 | Skin whitening agents containing glycosides | SHISEIDO COMPANY LIMITED (JP) | 1995-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140023602-A1 | EXTERNAL PREPARATION FOR SKIN CONTAINING A PHOSPHORYLATED SACCHARIDE | SI, CUTA, CD44 | TYR 149/4885SLC5A1 723/4885SLC5A2 553/4885 |
| US-11917995-B2 | Fungicidal compositions of mefentrifluconazole | METTL3, FBL, AADAC | TYR 219/4885SLC5A1 2874/4885SLC5A2 1603/4885 |
| US-20080274068-A1 | External Preparation for Skin Containing a Phosphorlated Saccharide | CUTA, SI, CD44 | TYR 113/4885SLC5A1 589/4885SLC5A2 424/4885 |
| US-20260047977-A1 | DEVICE AND METHOD OF USE FOR MEASURING AND MODIFYING THE ORBITAL AND INTRAORBITAL CONTENT, VOLUME, PULSALITY, LYMPHATIC DRAINAGE, VENOUS DRAINAGE, AND BLOOD FLOW | PROX1, EYA3, PDE6G | TYR 971/4885SLC5A1 2697/4885SLC5A2 2531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.